Information relating to the remuneration of Mr. Marc de Garidel, Chairman and CEO until July 18, 2016, Chairman of the Board of Directors since this date

Understanding the true impact of living with FOP

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria